APOA1 and coronary artery disorder: showed that sCD36 was negatively associated with apolipoprotein B/apolipoprotein A1 ratio, BMI, waist‐hip ratio, systolic blood pressure, left ventricular end‐diastolic diameter and volume, left atrium diameter, right ventricular end‐diastolic diameter and was positively correlated with high‐density lipoprotein cholesterol and apolipoprotein A1 concentration,69, 77 highlighting a protective role of higher sCD36 in patients with coronary artery disease.